Leveraging Family Office Networks for Strategic Growth
Discover how Family Office Networks can enhance collaboration and investment opportunities.

PYC is using its expertise in RNA drug design and proprietary drug delivery technology to bring a powerful new class of precision medicine to patients. With an initial focus on rare eye disease, PYC’s technology has the potential to unlock treatments for multiple types of genetic disease.
The company has proven the efficacy and safety of its lead drug program in patient-derived models and has launched formal studies in preparation for human clinical trials in 2021.

Discover how Family Office Networks can enhance collaboration and investment opportunities.

Join the Family Office Networks Webinar Series Featuring Hemptown USA. Eric Gripentrog, CEO will discuss hemp derived cannabinoids, including CBD and CBG,…

Come Join the Family Office Networks’ Webinar Series featuring Asalyxa Bio. Asalyxa Bio’s elegant technology platform enables targeted delivery of therapeutic compounds…
Protected by reCAPTCHA — the Google Privacy Policy and Terms of Service apply.